Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada

BACKGROUND: Little is known on the impact of emerging treatments for advanced melanoma (stages III and IV) on patients’ functioning and well-being. The objective of this study was to describe the patient-reported treatment-related symptom (TRS) burden in advanced melanoma. METHOD: Twenty-nine in-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Winson Y., White, Michelle K., Bayliss, Martha S., Stroupe, Angela, Lovley, Andrew, King-Kallimanis, Bellinda L., Lasch, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281076/
https://www.ncbi.nlm.nih.gov/pubmed/29934684
http://dx.doi.org/10.1007/s00520-018-4316-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281076/
https://www.ncbi.nlm.nih.gov/pubmed/29934684
http://dx.doi.org/10.1007/s00520-018-4316-9

Ejemplares similares